Study unveils how Toxoplasma gondii parasites escape drug treatment

A study by Indiana University School of Medicine researchers sheds new light on how Toxoplasma gondii parasites make the proteins they need to enter a dormant stage that allows them to escape drug treatment.

WM Technology Q1 Revenue Declines to $48 Million

WM Technology, Inc. Reports First Quarter 2023 Financial Results Announces First Quarter 2023 Financial Results with Revenue of $48.0 million Irvine, Calif. — May 9,

May 10, 2023

ProKidney drops Phase III CKD study to focus on US market and save up to $175m – Pharmaceutical Technology

The trials enrol patients with type 2 diabetes and chronic kidney disease (CKD). CKD can be a complication of type 2 diabetes. Credit: NTshutterth via

September 4, 2024

Genetic risk tool could aid early diagnosis and treatment of multiple sclerosis patients

Young people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.